California voters strike down drug prices cap

Published



The pharmaceutical industry won big on Tuesday after California voters rejected a ballot referendum that would have capped drug prices for certain state programs.

California voters reject Proposition 61, which would have forced drug companies to offer products for state healthcare programs at the same price paid by the U.S. Department of Veterans Affairs, which negotiates with drug makers for lower prices.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.